Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.

Colli Pee Novosanis

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Colli-Pee postal kits for home collection

Improving the quality of home-based urine collection by easy self-sampling, alongside postal packaging

Latest news

Novosanis brings Colli-Pee UAS FV-5040 with CE mark to the market offering a solution for oncology screening

Novosanis has received a CE-mark for their Colli-Pee ® with special preservative solution for oncology research applications.

Latest blogpost

Precision Medicine World Conference 2023
At this conference, OraSure Technologies, Inc. had speakers on behalf of its subsidiary companies Novosanis, Diversigen, and DNA Genotek. If you were unable to attend any of these four presentations, we have captured the highlights for you here.

Upcoming event

Eurogin 2023

Eurogin 2023

Bilbao, Spain
Novosanis is excited to meet you at EUROGIN, from 8 to 11 February in Bilbao, Spain. We are present with a booth (B07) and will share our newest results in scientific posters and scientific session. Scientific Posters - Jhana Hendrickx -'Home-based self-sampling of first void urine for hrHPV...